‘The UK is paying less for new cancer drugs than a number of other high income countries, according to a report in The Lancet Oncology.’ – BBC Health
Image source: Derek K. Miller
While the UK, Greece, Spain and Portugal pay the least, on average, for the drugs they use, Germany, Sweden and Switzerland pay the most.
The authors said more transparency was needed because some countries risked overpaying for drugs.
The pharmaceutical industry said the UK was getting a fair deal on medicines.
Prices of cancer drugs have risen steeply in recent years, placing major stress on many healthcare systems, including the NHS.
The report said drugs had accounted for nearly a third of the EU’s 51 billion euro (£37bn) cancer healthcare spending in 2009.
View the report abstract via the Lancet Oncology
Carry on reading the full commentry via BBC Health News